Literature DB >> 29617845

A Small-Molecule CD4-Mimetic Compound Protects Bone Marrow-Liver-Thymus Humanized Mice From HIV-1 Infection.

Amy M Princiotto1, Vladimir D Vrbanac2, Bruno Melillo3, Jongwoo Park3, Andrew M Tager2, Amos B Smith3, Joseph Sodroski1,4,5, Navid Madani1,4,6.   

Abstract

Background: Small-molecule CD4-mimetic compounds (CD4mc) inhibit human immunodeficiency virus (HIV-1) entry by blocking binding to the CD4 receptor and by premature triggering of the viral envelope glycoprotein (Env) spike.
Methods: The efficacy of a CD4mc in protecting bone marrow-liver-thymus (BLT) humanized mice from vaginal HIV-1 challenge was evaluated.
Results: Intravaginal application of the CD4mc JP-III-48, either before or simultaneously with virus challenge, protected BLT humanized mice from HIV-1JR-CSF infection in a dose- dependent manner.
Conclusion: The direct antiviral effects of a CD4mc prevent HIV-1 infection in a murine model of sexual transmission.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29617845      PMCID: PMC6049021          DOI: 10.1093/infdis/jiy174

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.

Authors:  W A O'Brien; Y Koyanagi; A Namazie; J Q Zhao; A Diagne; K Idler; J A Zack; I S Chen
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

Authors:  Francesca Curreli; Young Do Kwon; Dmitry S Belov; Ranjith R Ramesh; Alexander V Kurkin; Andrea Altieri; Peter D Kwong; Asim K Debnath
Journal:  J Med Chem       Date:  2017-03-16       Impact factor: 7.446

3.  Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

Authors:  Bruno Melillo; Shuaiyi Liang; Jongwoo Park; Arne Schön; Joel R Courter; Judith M LaLonde; Daniel J Wendler; Amy M Princiotto; Michael S Seaman; Ernesto Freire; Joseph Sodroski; Navid Madani; Wayne A Hendrickson; Amos B Smith
Journal:  ACS Med Chem Lett       Date:  2016-01-19       Impact factor: 4.345

4.  CD4 mimetics sensitize HIV-1-infected cells to ADCC.

Authors:  Jonathan Richard; Maxime Veillette; Nathalie Brassard; Shilpa S Iyer; Michel Roger; Loïc Martin; Marzena Pazgier; Arne Schön; Ernesto Freire; Jean-Pierre Routy; Amos B Smith; Jongwoo Park; David M Jones; Joel R Courter; Bruno N Melillo; Daniel E Kaufmann; Beatrice H Hahn; Sallie R Permar; Barton F Haynes; Navid Madani; Joseph G Sodroski; Andrés Finzi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

Review 5.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Authors:  R Wyatt; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

6.  CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.

Authors:  Navid Madani; Amy M Princiotto; Arne Schön; Judith LaLonde; Yu Feng; Ernesto Freire; Jongwoo Park; Joel R Courter; David M Jones; James Robinson; Hua-Xin Liao; M Anthony Moody; Sallie Permar; Barton Haynes; Amos B Smith; Richard Wyatt; Joseph Sodroski
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

7.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

8.  Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120.

Authors:  Navid Madani; Arne Schön; Amy M Princiotto; Judith M Lalonde; Joel R Courter; Takahiro Soeta; Danny Ng; Liping Wang; Evan T Brower; Shi-Hua Xiang; Young Do Kwon; Chih-Chin Huang; Richard Wyatt; Peter D Kwong; Ernesto Freire; Amos B Smith; Joseph Sodroski
Journal:  Structure       Date:  2008-11-12       Impact factor: 5.006

Review 9.  Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.

Authors:  Joel R Courter; Navid Madani; Joseph Sodroski; Arne Schön; Ernesto Freire; Peter D Kwong; Wayne A Hendrickson; Irwin M Chaiken; Judith M LaLonde; Amos B Smith
Journal:  Acc Chem Res       Date:  2014-02-06       Impact factor: 22.384

10.  Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.

Authors:  Hillel Haim; Zhihai Si; Navid Madani; Liping Wang; Joel R Courter; Amy Princiotto; Aemro Kassa; Marciella DeGrace; Kathleen McGee-Estrada; Megan Mefford; Dana Gabuzda; Amos B Smith; Joseph Sodroski
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  11 in total

1.  Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.

Authors:  Yijun Zhang; James H Chapman; Asim Ulcay; Richard E Sutton
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Blocking HIV-1 Infection by Chromosomal Integrative Expression of Human CD4 on the Surface of Lactobacillus acidophilus ATCC 4356.

Authors:  Wenzhong Wei; Joshua Wiggins; Duoyi Hu; Vladimir Vrbanac; Dane Bowder; Michael Mellon; Andrew Tager; Joseph Sodroski; Shi-Hua Xiang
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 3.  The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell; Mark Krystal
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.

Authors:  Saumya Anang; Jonathan Richard; Catherine Bourassa; Guillaume Goyette; Ta-Jung Chiu; Hung-Ching Chen; Amos B Smith; Navid Madani; Andrés Finzi; Joseph Sodroski
Journal:  J Virol       Date:  2022-08-18       Impact factor: 6.549

5.  Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.

Authors:  Annemarie Laumaea; Amos B Smith; Joseph Sodroski; Andrés Finzi
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

6.  Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Melissa C Grenier; Shilei Ding; Dani Vézina; Jean-Philippe Chapleau; William D Tolbert; Rebekah Sherburn; Arne Schön; Sambasivarao Somisetti; Cameron F Abrams; Marzena Pazgier; Andrés Finzi; Amos B Smith
Journal:  ACS Med Chem Lett       Date:  2019-11-15       Impact factor: 4.345

7.  Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir.

Authors:  Jyothi K Rajashekar; Jonathan Richard; Jagadish Beloor; Jérémie Prévost; Sai Priya Anand; Guillaume Beaudoin-Bussières; Liang Shan; Dietmar Herndler-Brandstetter; Gabrielle Gendron-Lepage; Halima Medjahed; Catherine Bourassa; Fleur Gaudette; Irfan Ullah; Kelly Symmes; Andrew Peric; Emily Lindemuth; Frederic Bibollet-Ruche; Jun Park; Hung-Ching Chen; Daniel E Kaufmann; Beatrice H Hahn; Joseph Sodroski; Marzena Pazgier; Richard A Flavell; Amos B Smith; Andrés Finzi; Priti Kumar
Journal:  Cell Host Microbe       Date:  2021-05-20       Impact factor: 31.316

8.  The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.

Authors:  Jérémie Prévost; William D Tolbert; Halima Medjahed; Rebekah T Sherburn; Navid Madani; Daria Zoubchenok; Gabrielle Gendron-Lepage; Althea E Gaffney; Melissa C Grenier; Sharon Kirk; Natasha Vergara; Changze Han; Brendan T Mann; Agnès L Chénine; Adel Ahmed; Irwin Chaiken; Frank Kirchhoff; Beatrice H Hahn; Hillel Haim; Cameron F Abrams; Amos B Smith; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  mBio       Date:  2020-05-26       Impact factor: 7.867

Review 9.  Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies.

Authors:  Yash Agarwal; Cole Beatty; Shivkumar Biradar; Isabella Castronova; Sara Ho; Kevin Melody; Moses Turkle Bility
Journal:  Retrovirology       Date:  2020-04-10       Impact factor: 4.602

10.  Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.

Authors:  Sai Priya Anand; Shilei Ding; William D Tolbert; Jérémie Prévost; Jonathan Richard; Hwi Min Gil; Gabrielle Gendron-Lepage; Wing-Fai Cheung; Haifeng Wang; Rebecca Pastora; Hirak Saxena; Warren Wakarchuk; Halima Medjahed; Bruce D Wines; Mark Hogarth; George M Shaw; Malcom A Martin; Dennis R Burton; Lars Hangartner; David T Evans; Marzena Pazgier; Doug Cossar; Michael D McLean; Andrés Finzi
Journal:  J Virol       Date:  2021-08-25       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.